Wollenhaupt J, Silverfield J, Lee B, et al. Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 8 years. EULAR 2017, THU0197.
Effectiviteit van rituximab bij polymyalgia rheumatica: een proof-of-concept studie
nov 2021